newsfilter
← Latest News
PR Newswire·

QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance

  • QuidelOrtho announced preliminary unaudited revenue of $615-$620 million for Q1 2026 ending March 29, 2026.
  • Lower revenue was driven by a 30% decline in U.S. Influenza-like Illness visits compared to Q1 2025, slower China distributor sales linked to proposed NHSA reimbursement reductions, & delayed EMEA orders due to the Middle East conflict.
  • The company expects free cash flow of $(65) to $(70) million for Q1 2026, with full-year 2026 free cash flow projected to remain positive.
  • QuidelOrtho maintains that the low end of its full-year 2026 financial guidance issued on February 11, 2026, remains achievable.
  • Final Q1 2026 financial results & an update on full-year guidance will be released on May 5, 2026, after market close.
  • An earnings conference call regarding the results is scheduled for May 5, 2026, at 2:00 p.m. PT / 5:00 p.m. ET.
  • Core business segments account for more than 70% of total revenue & are described as strong despite macroeconomic challenges.
  • The preliminary revenue figures are based on management's initial analysis & are subject to adjustments following the quarter-end financial close.